Smith W Keith
President at DRCT; Director at XRAY
- Sold, on record
- $2.5M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Nov 14, 2025
- Form 144 notices
- 5
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
Sales by reason
8
Routine
2
Plan not stated
1
No plan
3
Unusual
Form 4 sales per year, every sale on record.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- Nov 14, 2025Unusual
Sold 27.3% of their holdings
$47k171,242 shares at $0.28
- Nov 13, 2025Notice
Filed a notice to sell 600,000 shares
$210k600,000 shares
- Jul 28, 2025Routine
Sold 53.6% of their holdings
$17k32,750 shares at $0.53
- Jul 23, 2025Routine
Sold 42% of their holdings
$23k44,242 shares at $0.51
- Jul 18, 2025Routine
Sold 32.7% of their holdings
$27k51,132 shares at $0.52
- Jul 15, 2025Routine
Sold 15.4% of their holdings
$16k28,576 shares at $0.55
- Jul 14, 2025Notice
Filed a notice to sell 185,000 shares
$110k185,000 shares
- Mar 27, 2025Routine
Sold 100% of their holdings
$31k40,449 shares at $0.78
- Mar 24, 2025Routine
Sold 44% of their holdings
$25k31,762 shares at $0.77
- Mar 19, 2025Routine
Sold 24.9% of their holdings
$19k23,953 shares at $0.77
10 of 19
Every transaction
Loading transactions…
Sales and notices (19)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | Nov 17, 2025 | DRCT | President | Form 4 sale | 171,242 | $47k | 27.3% | Unusual | SEC |
| Nov 13, 2025 | Nov 14, 2025 | DRCT | OFFICER | Form 144 notice | 600,000 | $210k | Notice | SEC | |
| Jul 28, 2025 | Jul 28, 2025 | DRCT | President | Form 4 sale | 32,750 | $17k | 53.6% | Routine | SEC |
| Jul 23, 2025 | Jul 23, 2025 | DRCT | President | Form 4 sale | 44,242 | $23k | 42.0% | Routine | SEC |
| Jul 18, 2025 | Jul 18, 2025 | DRCT | President | Form 4 sale | 51,132 | $27k | 32.7% | Routine | SEC |
| Jul 15, 2025 | Jul 16, 2025 | DRCT | President | Form 4 sale | 28,576 | $16k | 15.4% | Routine | SEC |
| Jul 14, 2025 | Jul 14, 2025 | DRCT | Officer | Form 144 notice | 185,000 | $110k | Notice | SEC | |
| Mar 27, 2025 | Mar 27, 2025 | DRCT | President | Form 4 sale | 40,449 | $31k | 100.0% | Routine | SEC |
| Mar 24, 2025 | Mar 24, 2025 | DRCT | President | Form 4 sale | 31,762 | $25k | 44.0% | Routine | SEC |
| Mar 19, 2025 | Mar 19, 2025 | DRCT | President | Form 4 sale | 23,953 | $19k | 24.9% | Routine | SEC |
| Mar 14, 2025 | Mar 17, 2025 | DRCT | President | Form 4 sale | 34,558 | $28k | 26.4% | Routine | SEC |
| Mar 12, 2025 | Mar 12, 2025 | DRCT | Officer | Form 144 notice | 173,185 | $166k | Notice | SEC | |
| Nov 15, 2024 | Nov 19, 2024 | DRCT | President | Form 4 sale | 313 | $563 | 0.4% | No plan | SEC |
| Nov 15, 2024 | Nov 15, 2024 | DRCT | Officer | Form 144 notice | 208,013 | $401k | Notice | SEC | |
| Dec 12, 2023 | Dec 13, 2023 | DRCT | President | Form 4 sale | 119,278 | $1.3M | 47.7% | Unusual | SEC |
| Dec 4, 2023 | Dec 5, 2023 | DRCT | an officer and director of the issuer | Form 144 notice | 250,000 | $3M | Notice | SEC | |
| Aug 26, 2022 | Aug 30, 2022 | DRCT | President | Form 4 sale | 60,000 | $188k | 60.0% | Unusual | SEC |
| Aug 19, 2009 | Aug 20, 2009 | XRAY | Director | Form 4 sale | 15,200 | $494k | 18.7% | Plan not stated | SEC |
| May 21, 2009 | May 21, 2009 | XRAY | Director | Form 4 sale | 10,372 | $302k | 11.3% | Plan not stated | SEC |